VALN · NASDAQ · Biotechnology

Valneva (ADR)

Develops, manufactures, and sells travel vaccines alongside infectious-disease vaccine programs.

$6.43
After-hours close−0.02 (−0.31%)
At close$6.45(−1.61%)

Breakdown13F · Form 4

Institutions 4.12%Insiders

Shares outstanding 94.82M · Float 90.33M · 95.3% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Caisse des depots et consignations19.07M9.30%13DMay 12, 2026
Frazier Life Sciences Management, L.P.2.29M2.42%13FMay 15, 2026
Novo Holdings A/S1.06M1.12%13FMay 15, 2026
General American Investors Co Inc354.4K0.37%13FMay 1, 2026
Wells Fargo & Company/MN78.0K0.08%13FJul 8, 2026

Institutions13F, as of Mar 31, 2026

21 holders · 3.91M shares · 5 new positions · 8 increased · 5 reduced · 3 closed

HolderShares% outstandingChg q/qFiled
Frazier Life Sciences Management, L.P.2.29M2.42%0May 15, 2026
Novo Holdings A/S1.06M1.12%−1.25MMay 15, 2026
General American Investors Co Inc354.4K0.37%0May 1, 2026
Wells Fargo & Company/MN78.0K0.08%−45.4KJul 8, 2026
Morgan Stanley46.9K0.05%+3.9KMay 15, 2026
Ironwood Investment Management LLC25.1K0.03%0May 15, 2026
HRT Financial LP20.8K0.02%+20.8KnewMay 14, 2026
Old Mission Capital LLC13.8K0.01%+13.8KnewMay 15, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Caisse des depots et consignationsincl. Bpifrance Participations S.A., EPIC Bpifrance +2 more9.30%19.07M13DMay 12, 2026
Caisse des dépôts et consignationsincl. CDC Croissance S.A., Bpifrance Participations S.A. +2 more8.60%14.11M13D/ASep 20, 2024

InsidersForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.